(a) Genomic PCR detection of Trim33 in BMDM and PM (top) and western blot analysis of TRIM33 in BMDM from WT and Trim33−/− mice (bottom). (b) Kinetics of Ifnb1 mRNA levels in WT and Trim33−/− BMDM (left panel) or PM (right panel) after activation with LPS. Mean±s.e.m., n=3 to 6. (c) IFN-β protein levels in supernatants of non-activated and LPS-activated WT and Trim33−/− BMDM. Mean±s.e.m., n=4. (d) Relative mRNA levels of Ifnb1 and IFN-β target genes in Trim33−/− BMDM versus WT BMDM treated with LPS (0.1 ng ml−1) for 3 or 24 h. Mean±s.e.m., n=3. (e) Kinetics of Ifna mRNA levels in WT and Trim33−/− BMDM activated with LPS. Mean±s.e.m., n=3. (f) Kinetics of Ifnb1 mRNA levels in NIH3T3 cells expressing a shRNA targeting Trim33 (NIH3T3 TRIM33−) or luciferase (NIH3T3 TRIM33+) and activated with poly(I:C). Mean±s.e.m., n=3. (g) Kinetics of Ifnb1 mRNA levels in WT and Trim33−/− iM treated for the indicated times with LPS. Mean±s.e.m., n=3. (h) Relative expression of Ifnb1 mRNA 0, 2 and 8 h after LPS treatment of Trim33−/− iM transduced with a lentivirus coding for GFP (iM Trim33−/− +GFP), for full-length flag-TRIM33 and GFP (iM Trim33−/− +flag-TRIM33) or for flag-TRIM33 mutants lacking the coiled-coil domain (iM Trim33−/− +flag-ΔCC), the ubiquitin ligase activity (iM Trim33−/− +flag-ΔUb) or the SMAD-interaction domain (iM Trim33−/− +flag-ΔSMAD). Mean±s.e.m., n=5. All qRT-PCR data are normalized to HPRT and, unless otherwise indicated, presented relative to expression of untreated WT cells. *P<0.05; **P<0.01 and ***P<0.001, Mann–Whitney test.